Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Rose Biomedical Development Corporation for $151,892.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI063892-01 | Phase I | 151,892 | ||||||||
A STTR Phase I contract was awarded to Rose Biomedical Development Corporation for $145,155.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL083331-01A1 | Phase I | 145,155 | ||||||||
A SBIR Phase I contract was awarded to Rose Biomedical Development Corporation for $151,892.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41AI063892-01 | Phase I | 151,892 | ||||||||
A SBIR Phase I contract was awarded to Rose Biomedical Development Corporation for $145,313.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL080826-01 | Phase I | 145,313 | ||||||||
A SBIR Phase I contract was awarded to Rose Biomedical Development Corporation for $99,972.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI051751-01A2 | Phase I | 99,972 | ||||||||
A SBIR Phase I contract was awarded to Rose Biomedical Development Corporation for $99,495.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL065903-01A2 | Phase I | 99,495 | ||||||||
A SBIR Phase I contract was awarded to Rose Biomedical Development Corporation for $111,716.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL073586-01A2 | Phase I | 111,716 | ||||||||
A SBIR Phase I contract was awarded to Rose Biomedical Development Corporation for $145,155.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41HL083331-01A1 | Phase I | 145,155 | ||||||||
A SBIR Phase II contract was awarded to Rose Biomedical Development Corporation for $749,645.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL065903-02A1 | Phase II | 749,645 | ||||||||
A SBIR Phase I contract was awarded to Rose Biomedical Development Corporation for $99,841.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 99,841 |